Bass Oil (ASX:BAS) $3m Raise Funds Vanessa Gas Deal and Bunian 6 Drill
Capital Raised, Now Execution on Vanessa Starts
Bass Oil has completed a A$3M share placement, issuing 47 million shares at A$0.063 per share to a mix of existing shareholders and new institutional investors.
The pricing came at a fairly steep discount, around 13% below the last traded price of A$0.072 per share. It also reflected a 25% discount to VWAP, which suggests the company needed to price the deal aggressively to get it away.
At the same time, Bass Oil placement was described as strongly supported, which tells us demand was likely there. The bigger issue appears to have been structuring the deal at terms attractive enough to bring in new institutional capital.
What are the Best ASX Stocks to invest in right now?
Check our buy/sell tips
What is the Bass Oil capital being used for?
The company is allocating the capital toward completing the Vanessa gas field acquisition, which is the key catalyst, as well as drilling the Bunian 6 oil well in Indonesia.
The Vanessa gas field is the strategic centrepiece. Bass has already secured a binding three-year gas supply agreement with Origin Energy, signed in December 2025, covering all gas produced from the field. Once commissioned, that would make Bass a new entrant into the East Coast Gas Market, which is where the real value story sits given the ongoing supply tightness on the east coast.
The investor’s takeaway for Bass Oil
This is a small-cap capital raise doing two things at once. It is funding a near-term production catalyst through Indonesian oil drilling, while also positioning the company for a much more meaningful entry into the East Coast gas market through Vanessa and the Origin Energy agreement.
The Origin offtake contract materially de-risks the gas side of the story because it gives Bass a clear pathway to monetising production once the field is up and running.
The key risk now is execution. The market will be watching whether commissioning stays on schedule and whether Bunian 6 can deliver the expected production uplift by mid-year.
Blog Categories
Get the Latest Insider Trades on ASX!
Recent Posts
Telix (ASX:TLX) Pixclara NDA Resubmitted, The FDA Clock Restarts
Pixclara Back With the FDA Telix has resubmitted its NDA to the FDA for Pixclala, its PET imaging agent for…
The Most Shorted ASX Stocks This March
Here are the most shorted ASX stocks in March When a stock has a high short interest, it means a…
Lynas (ASX:LYC): US$96m DoD Allocation and a US$110 Floor, The New Baseline
The Most Important Change Is Not Demand, It’s Downside Protection Lynas has had a very strong start to the year,…